دورية أكاديمية

Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass.

التفاصيل البيبلوغرافية
العنوان: Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass.
المؤلفون: Ferreira, Antonio, Schönenberger, Katja A., Potoczna, Natascha, Vogt, Andreas, Gerber, Philipp A., Zehetner, Jörg, Giachino, Daniel, Nett, Philipp, Gawinecka, Joanna, Cossu, Luca, Fuster, Daniel G., Dalla Man, Chiara, Facchinetti, Andrea, Melmer, Andreas, Nakas, Christos T., Hepprich, Matthias, Donath, Marc Y., Herzig, David, Bally, Lia
المصدر: Diabetes Technology & Therapeutics; Jul2023, Vol. 25 Issue 7, p467-475, 9p
قاعدة البيانات: Complementary Index
الوصف
تدمد:15209156
DOI:10.1089/dia.2023.0036